Publicaciones en las que colabora con Rosario García de Vicuña (11)

2023

  1. Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

    Frontiers in Medicine, Vol. 10

2022

  1. VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures

    International journal of molecular sciences, Vol. 23, Núm. 15

2020

  1. Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders

    Journal of Autoimmunity, Vol. 111

2018

  1. Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity

    Reumatologia Clinica, Vol. 13, Núm. 6, pp. 318-325

2016

  1. Clinical relevance of VPAC1 receptor expression in early arthritis: Association with IL-6 and disease activity

    PLoS ONE, Vol. 11, Núm. 2

2015

  1. Biomarkers predicting a need for intensive treatment in patients with early arthritis

    Current Pharmaceutical Design, Vol. 21, Núm. 2, pp. 170-181

  2. The minor allele of rs7574865 in the STAT4 gene is associated with increased mRNA and protein expression

    PLoS ONE, Vol. 10, Núm. 11

  3. Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity

    Journal of Molecular Neuroscience, Vol. 56, Núm. 3, pp. 577-584

2014

  1. Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis

    PLoS ONE, Vol. 9, Núm. 1

2010

  1. Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker

    European Cytokine Network, Vol. 21, Núm. 3, pp. 186-194